Why the study?
Hyponatraemia frequently complicates aneurysmal subarachnoid haemorrhage and worsens outcomes, but whether fludrocortisone improves clinical outcomes remains unknown.
Does fludrocortisone improve functional outcomes at 6 months in adult patients with acute aneurysmal subarachnoid haemorrhage?
Does fludrocortisone improve functional outcomes at 6 months in adult patients with acute aneurysmal subarachnoid haemorrhage?
Answers are grounded in this paper and cite their sources.
This is a study protocol for a phase 3 trial evaluating whether 14 days of fludrocortisone improves 6-month functional outcomes in patients with acute aneurysmal subarachnoid hemorrhage.
Background and rationale: Hyponatraemia is a common complication after aneurysmal subarachnoid haemorrhage (aSAH) and is associated with worse outcomes. Fludrocortisone, a synthetic mineralocorticoid, may be an effective treatment for hyponatraemia, but its effect on clinical outcomes is unknown. Objectives: The objective of this study was to describe the study protocol for the Fludrocortisone in Aneurysmal Subarachnoid Haemorrhage (FLASH) trial. Design setting and participants: The FLASH trial is a phase three randomised, blinded, placebo-controlled, multicentre trial comparing 14 days of treatment with fludrocortisone to matching placebo in adult patients with acute aSAH at hospitals in Australia, New Zealand, and the United Kingdom. The planned sample size is 524 patients. Main outcome measures: The primary outcome measure is the Modified Rankin Scale score assessed at 6 months after randomisation. The secondary outcome is the Subarachnoid Haemorrhage Outcome Tool score assessed at the same time point. Tertiary outcomes are based on international guidelines for core outcome sets and include economic and quality-of-life analyses. Prespecified subgroups for analysis will comprise aSAH severity and the presence of hyponatraemia at randomisation. Results and conclusions: The FLASH trial aims to commence recruitment in May 2025. Trial registration: NCT06409364.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: